Aristotle University Of Thessaloniki (AUTH)
Development of holistic analytical methods for disease biomarker discovery and the study of drug efficasy in autoimmune disease
Abstract
dc:descriptionAutoimmunity characterises a biological state within which the immune system fails to recognise the host leading to a cascade of self attacks. Rheumatoind Arthritis has been often regarded as a prototype autoimmune disease due to clear role of autoimmunity in disease manifestation. Clinical indications of RA are symmetrical polyarthritis and joint swelling that progressively causes bone erosion and cartilage destruction leaving patients in severe pain and disability. Currently RA diagnostic tools employ radiographic imaging and clinical examinations of immunological markers such as RF and ACPA, fail to provide adequate diagnostic power at early disease onset with inevitable consequences to patients life quality. On this PhD project metabolic profile technologies are employed to study RA biology in the hunt of metabolites with clear association to disease manifestation. Global and targeted LC-MS based metabolite approaches were applied for the analysis of urine, serum, hind limb joint and synovial fibroblasts extracts. All samples were collected from in vivo model TG197 that closely mimics the human TNFa RA expression that could potentially help the translation of the finding into the clinic. For this purpose a targeted LC-MS based analytical platform was successfully developed and validated using an ion pair chromatographic separation that enabled detection of more than a hundred polar metabolic intermediates involved in key metabolic pathways. Dried biofluid spot technology was also investigated as alternative to liquid biofluid storage. Short term stability (24hours) study revealed close proximity of the metabolic phenotype of the DBS samples and those of the protein precipitated samples. However medium (1 week) to long (1 month) term stability at room temperature was found poor but card storage at -20ºC or below can improve stability. Global urine metabolic analysis revealed clear differentiation between TG and WT phenotype across all weeks starting from 6 up to 11 weeks of mouse age. Remicade treatment of TG animals found beneficial in progressive swift of the metabolic phenotype from TG to WT like one. Strong evidence of phenotypic differentiation with steroid related marker was found. On the other hand targeted metabolic analysis identified itaconic acid as a proximal marker to RA expression. Serum global metabolite analysis were also shown clear differentiation between TG and WT phenotype. Targeted metabolic profile provided more easily interpreted data with major metabolic differences corresponding to aminoacids and central carbon metabolism. Similarly to urine, itaconic acid revealed strong correlation with disease expression and with potential of non-invasive marker monitoring capability. On line lithium adduct formation combined with ion mobility separation was investigated and unravelled its potential in enhancing lipid fragmentation data associated with differentiating lipid species between TG and WT organic hind limb extracts. Metabolic changes associated primarily with energy producing metabolic pathways (glycolysis, starch metabolism) were found following targeted analysis of aqueous hind limb extracts. To our best of knowledge this is the first time that LC-MS metabolic profiling approaches was implemented to RA biology on the TG197 in vivo model and its responses to standard of care anti-TNFa (Remicade) treatment.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Michopoulos, Filippos
- Μιχόπουλος, Φίλιππος
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35457